Name: Pseudomonas paraeruginosa PA7
Creator: BacDive
License: http://creativecommons.org/licenses/by-nc/4.0/

Strain identifier

BacDive ID: 12760

Type strain:

Species: Pseudomonas paraeruginosa

Strain Designation: PA7, R. Hugh 813

Culture col. no.: DSM 1128, ATCC 9027, CIP 82.118, DSM 1385, WDCM 00026, CCUG 22801, CCM 1961, IAM 10374, IFO 13275, JCM 23217, BUCSAV 278, IAM 13074, JCM 14171, NBRC 13275, NCIMB 8626, NRRL B-800, CIP 72.26, IMET 10905, NCTC 12924, CECT 111, LMG 8029, CMCC (B) 10104

Strain history: CIP <- 1983, ATCC <- C.P. Hegarty, strain: R. Hugh 813

NCBI tax ID(s): 287 (species)

SI-ID 3893

LMG 8029, ATCC 9027, DSM 1128, ATCC 97, NRRL B-247, NRRL B-800, CCM 1961, IAM 10374, IFO 13275, NCIMB 8626, CCUG 22801, IMET 10905, NCIB 8626, NCTC 12924, IMI 349018, CIP 82.118, CIP 72.26, CECT 111, CCRC 11633, KCTC 2513, NCCB 91026, LMD 91.26, NBRC 13275, BCRC 11633, CBMAI 602, CCT 1987, CCT 2563, NBIMCC 1390, NCAIM B.01687, NCIM 2200, NCIM 2242, CDBB 1110, ACM 3378, CNCTC 5664, CGMCC 1.2421, VTT E-96728, DSM 1385

Section

Pseudomonas paraeruginosa PA7 is an obligate aerobe, mesophilic, motile human pathogen that has multiple antibiotic resistances and was isolated from outer ear infection.

antibiotic resistance
motile
human pathogen
mesophilic
obligate aerobe
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Pseudomonadota*
	Class	*Gammaproteobacteria*
	Order	*Pseudomonadales*
	Family	*Pseudomonadaceae*
	Genus	*Pseudomonas*
	Species	**Pseudomonas paraeruginosa**
	Full Scientific Name (LPSN)	Pseudomonas paraeruginosa Rudra et al. 2022

Information on morphological and physiological properties Morphology

[Ref.: #116095]	Gram stain	negative
[Ref.: #69480]	Gram stain	negative Confidence in %99.986

[Ref.: #116095]	Cell shape	rod-shaped

[Ref.: #116095]	Motility	yes
[Ref.: #69480]	Motility	yes Confidence in %98.925

Information on culture and growth conditions Culture and growth conditions

[Ref.: #572]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #572]

Culture medium growth

[Ref.: #572]

Culture medium link

Medium recipe at MediaDive

[Ref.: #572]

Culture medium composition

expand / minimize

[Ref.: #572]

Culture medium

NUTRIENT AGAR (DSMZ Medium 1)

[Ref.: #572]

Culture medium growth

[Ref.: #572]

Culture medium link

Medium recipe at MediaDive

[Ref.: #572]

Culture medium composition

expand / minimize

[Ref.: #41819]

Culture medium

MEDIUM 72- for trypto casein soja agar

[Ref.: #41819]

Culture medium growth

[Ref.: #41819]

Culture medium composition

expand / minimize

[Ref.: #572]

Culture medium

TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)

[Ref.: #572]

Culture medium growth

[Ref.: #572]

Culture medium link

Medium recipe at MediaDive

[Ref.: #572]

Culture medium composition

expand / minimize

[Ref.: #116095]

Culture medium

CIP Medium 72

[Ref.: #116095]

Culture medium growth

[Ref.: #116095]

Culture medium link

Medium recipe provided by DSMZ

[Ref.: #116095]

Culture medium

CIP Medium 3

[Ref.: #116095]

Culture medium growth

[Ref.: #116095]

Culture medium link

Medium recipe provided by DSMZ

	Kind of temperature		Temperature
[Ref.: #572]		growth	37 °C
[Ref.: #41819]		growth	30 °C
[Ref.: #67770]		growth	30 °C
[Ref.: #116095]		growth	10-41 °C
[Ref.: #116095]	no	growth	5 °C

[Ref.: #572]	Temperature range	mesophilic
[Ref.: #41819]	Temperature range	mesophilic
[Ref.: #67770]	Temperature range	mesophilic
[Ref.: #116095]	Temperature range	psychrophilic

Information on physiology and metabolism Physiology and metabolism

[Ref.: #116095]

Oxygen tolerance

obligate aerobe

Note that the displayed test results represent raw data and therefore may deviate!

Antibiotic susceptibility testing

Test 1

Test 2

Test 3

Test 4

Test 5

Test 6

Test 7

Test 8

Test 9

Reference

[Ref.: #572]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
resistant0
resistant0
resistant0
28
20
resistant0
resistant0
24
28-30
28
12
10
20
24
resistant0
8
resistant0
24
30
14
16
resistant0
resistant0
16
12
18
10
24
resistant0
36
24
resistant0
resistant0
resistant0
resistant0
28

[Ref.: #572]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
resistant0
resistant0
resistant0
28
20
resistant0
resistant0
22-24
30
28
12-14
12
24-26
28
resistant0
8
resistant0
26
30-32
16
18
resistant0
resistant0
18
12-14
18
10
24
resistant0
36
24
resistant0
resistant0
resistant0
resistant0
28

[Ref.: #572]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
resistant0
resistant0
resistant0
28-30
20
resistant0
resistant0
24
30
26-28
12
12
22
26
resistant0
10
resistant0
24
32
14
16-18
resistant0
resistant0
16
12
18
10
24
resistant0
36
24
resistant0
resistant0
resistant0
resistant0
26

[Ref.: #572]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
resistant0
resistant0
resistant0
28
20-22
resistant0
resistant0
24
30
28
12
16-18
20-22
24-26
resistant0
18
resistant0
24-26
30
14
16-18
resistant0
resistant0
14-16
12
16-18
8
24
resistant0
36-38
24
resistant0
resistant0
resistant0
resistant0
26-28

[Ref.: #572]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
resistant0
resistant0
resistant0
28
20
resistant0
resistant0
22
30
28-30
12
12
22
24-26
resistant0
6
resistant0
24
32
14-16
18
resistant0
resistant0
14-16
26
18
8
24
resistant0
36-38
24
resistant0
resistant0
resistant0
resistant0
28

[Ref.: #572]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
resistant0
resistant0
resistant0
28-30
22
resistant0
resistant0
26
30
28
10
12
22
26
resistant0
10
resistant0
24
30
12-14
16
resistant0
resistant0
16
14
18
6
26
resistant0
36
24
resistant0
resistant0
resistant0
resistant0
28

[Ref.: #572]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
resistant0
resistant0
resistant0
26-28
20
resistant0
resistant0
22
28
26
8-10
10
18-20
26
resistant0
6
resistant0
24
30
14
14
resistant0
resistant0
16
10-12
18
8
20
resistant0
32-34
20-22
resistant0
resistant0
resistant0
resistant0
26-28

[Ref.: #572]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
resistant0
resistant0
resistant0
26-28
20
resistant0
resistant0
22
28
26
8-10
10
18-20
26
resistant0
6
resistant0
24
30
14
14
resistant0
resistant0
16
10-12
18
8
20
resistant0
32-34
20-22
resistant0
resistant0
resistant0
resistant0
26-28

[Ref.: #572]
Mueller Hinton
37

aerob
yes
Inhibition zone diameter in mm
resistant0
resistant0
resistant0
26-28
18
resistant0
resistant0
22-24
28
28
10
14
20
24
resistant0
resistant0
resistant0
22
30
14
14
resistant0
resistant0
16
10
18
6
24
resistant0
34
22
resistant0
resistant0
resistant0
resistant0
26

Only first 15 entries are displayed. Click here to see all.

[Ref.: #69481]	Ability of spore formation	no Confidence in %100
[Ref.: #69480]	Ability of spore formation	no Confidence in %99.979

[Ref.: #572]

Name of produced compound

rhamnolipid

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68369]	adipate ChEBI	+	assimilation	* from API 20NE
[Ref.: #68369]	arginine ChEBI	+	hydrolysis	* from API 20NE
[Ref.: #68369]	D-glucose ChEBI	+	assimilation	* from API 20NE
[Ref.: #68369]	D-mannitol ChEBI	+	assimilation	* from API 20NE
[Ref.: #68369]	D-mannose ChEBI	-	assimilation	* from API 20NE
[Ref.: #68369]	decanoate ChEBI	+	assimilation	* from API 20NE
[Ref.: #68369]	esculin ChEBI	-	hydrolysis	* from API 20NE
[Ref.: #68369]	gelatin ChEBI	+	hydrolysis	* from API 20NE
[Ref.: #68369]	gluconate ChEBI	+	assimilation	* from API 20NE
[Ref.: #68369]	L-arabinose ChEBI	-	assimilation	* from API 20NE
[Ref.: #68369]	malate ChEBI	+	assimilation	* from API 20NE
[Ref.: #68369]	maltose ChEBI	-	assimilation	* from API 20NE
[Ref.: #68369]	N-acetylglucosamine ChEBI	+	assimilation	* from API 20NE
[Ref.: #116095]	nitrate ChEBI	+	reduction
[Ref.: #116095]	nitrite ChEBI	+	reduction
[Ref.: #68369]	tryptophan ChEBI	-	energy source	* from API 20NE
	Only first 10 entries are displayed. Click here to see all.

	Metabolite production	Metabolite	Production
[Ref.: #116095]		indole ChEBI	no
[Ref.: #68369]		indole ChEBI	no	* from API 20NE

	Physiological tests	Metabolite	Indole test
[Ref.: #68369]		indole ChEBI	-	* from API 20NE

	Enzyme	Enzyme activity	EC number
[Ref.: #68382]	acid phosphatase	+	3.1.3.2	* from API zym
[Ref.: #68382]	alkaline phosphatase	+	3.1.3.1	* from API zym
[Ref.: #68382]	alpha-chymotrypsin	-	3.4.21.1	* from API zym
[Ref.: #68382]	alpha-fucosidase	-	3.2.1.51	* from API zym
[Ref.: #68382]	alpha-galactosidase	-	3.2.1.22	* from API zym
[Ref.: #68382]	alpha-glucosidase	-	3.2.1.20	* from API zym
[Ref.: #68382]	alpha-mannosidase	-	3.2.1.24	* from API zym
[Ref.: #68369]	arginine dihydrolase	+	3.5.3.6	* from API 20NE
[Ref.: #68382]	beta-galactosidase	-	3.2.1.23	* from API zym
[Ref.: #68369]	beta-glucosidase	-	3.2.1.21	* from API 20NE, API zym
[Ref.: #68382]	beta-glucuronidase	-	3.2.1.31	* from API zym
[Ref.: #116095]	catalase	+	1.11.1.6
[Ref.: #68382]	cystine arylamidase	-	3.4.11.3	* from API zym
[Ref.: #68369]	cytochrome oxidase	+	1.9.3.1	* from API 20NE
[Ref.: #68382]	esterase (C 4)	+		* from API zym
[Ref.: #68382]	esterase lipase (C 8)	+		* from API zym
[Ref.: #68369]	gelatinase	+		* from API 20NE
[Ref.: #68382]	leucine arylamidase	+	3.4.11.1	* from API zym
[Ref.: #68382]	lipase (C 14)	+		* from API zym
[Ref.: #68382]	N-acetyl-beta-glucosaminidase	-	3.2.1.52	* from API zym
[Ref.: #68382]	naphthol-AS-BI-phosphohydrolase	+		* from API zym
[Ref.: #116095]	oxidase	+
[Ref.: #68382]	trypsin	+	3.4.21.4	* from API zym
[Ref.: #116095]	urease	-	3.5.1.5
[Ref.: #68382]	valine arylamidase	-		* from API zym
	Only first 10 entries are displayed. Click here to see all.

Fatty acid profile

Metadata FA analysis

Reference

[Ref.: #47686]

Fatty acid	Percentage	ECL
C18:1 ω7c /12t/9t	31.9	17.824
C16:0	26.5	16
C16:1 ω7c	15.1	15.819
C12:0 2OH	5.2	13.178
C19:0 CYCLO ω8c	4.4	18.9
C10:0 3OH	4.1	11.423
C12:0 3OH	3.9	13.455
C12:0	3.2	12
C17:0 CYCLO	2.7	16.888
C14:0	0.9	14
C18:2 ω6,9c/C18:0 ANTE	0.6	17.724
C15:0	0.5	15
C18:0	0.4	18
C18:1 ω9c	0.3	17.769
C17:1 ω8c	0.2	16.792
C17:0	0.2	17

Metadata FA analysis

Reference

[Ref.: #47686]

Fatty acid	Percentage	ECL
C18:1 ω7c /12t/9t	28.4	17.824
C16:0	23.4	16
C16:1 ω7c	16.6	15.819
C12:0 2OH	5.4	13.178
C10:0 3OH	4.5	11.423
C12:0 3OH	4.3	13.455
C12:0	4.1	12
Unidentified	3.8	16.296
Unidentified	3.1	18.14
C19:0 CYCLO ω8c	1.5	18.9
C15:0 ISO 3OH	1.3	16.135
C17:0 CYCLO	1.3	16.888
C14:0	1	14
C15:0	0.5	15
C18:2 ω6,9c/C18:0 ANTE	0.4	17.724
C18:1 ω9c	0.3	17.769

API® 20NE:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Reduction of nitratesNO3	Indole productionTRP	Fermentation of D-glucoseGLU_ Ferm	Arginine dihydrolaseADH (Arg)	Urease/urea hydrolysisURE	Esculin hydrolysis/beta-GlucosidaseESC	Gelatinase/gelatin hydrolysisGEL	beta-GalactosidasePNPG	Assimilation of D-glucoseGLU_ Assim	Assimilation of L-arabinoseARA	Assimilation of D-mannoseMNE	Assimilation of D-mannitolMAN	Assimilation of N-acetyl-glucosamineNAG	Assimilation of maltoseMAL	Assimilation of gluconateGNT	Assimilation of capric acidCAP	Assimilation adipic acidADI	Assimilation of malic acidMLT	Assimilation of citric acidCIT	Assimilation of phenyl-acetic acidPAC	Cytochrome oxidaseOX
[Ref.: #572]	25316	-	-	+/-	+	+	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
[Ref.: #572]	25019	-	-	-	+	+/-	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
[Ref.: #572]	24747	+	-	-	+	+/-	-	+	+/-	+	-	-	+	+	-	+	+	+	+	+	-	+
[Ref.: #572]	24589	+	-	-	+	-	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
[Ref.: #47686]	7415	+	-	+	+	+	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
[Ref.: #572]	23047	+	-	-	+	+	-	+	+	+	-	-	+	+	-	+	+	+	+	+	-	+

API® Biotype100:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	ControlQ	D-glucose as carbon sourceGLU	D-fructose as carbon sourceFRU	D-galactose as carbon sourceGAL	D-trehalose as carbon sourceTRE	D-mannose as carbon sourceMNE	L-sorbose as carbon sourceSBE	D-melibiose as carbon sourceMEL	sucrose as carbon sourceSAC	D-raffinose as carbon sourceRAF	maltotriose as carbon sourceMTE	maltose as carbon sourceMAL	lactose as carbon sourceLAC	lactulose as carbon sourceLTE	1-O-methyl-beta-galactopyranoside as carbon sourceMbGa	1-O-methyl-alpha-galactopyranoside as carbon sourceMaGa	D-cellobiose as carbon sourceCEL	gentiobiose as carbon sourceGEN	1-O-methyl-beta-D-glucopyranoside as carbon sourceMbGu	esculin as carbon sourceESC	D-ribose as carbon sourceRIB	L-arabinose as carbon sourceARA	D-xylose as carbon sourceXYL	palatinose as carbon sourcePLE	L-rhamnose as carbon sourceRHA	L-fucose as carbon sourceFUC	D-melezitose as carbon sourceMLZ	D-arabitol as carbon sourceDARL	L-arabitol as carbon sourceLARL	xylitol as carbon sourceXLT	dulcitol as carbon sourceDUL	D-tagatose as carbon sourceTAG	glycerol as carbon sourceGLY	myo-inositol as carbon sourceINO	D-mannitol as carbon sourceMAN	maltitol as carbon sourceMTL	D-turanose as carbon sourceTUR	D-sorbitol as carbon sourceSOR	adonitol as carbon sourceADO	hydroxyquinoline-beta-glucuronide as carbon sourceHBG	D-lyxose as carbon sourceLYX	i-erythritol as carbon sourceERY	1-O-methyl-alpha-D-glucoside as carbon sourceMDG	3-O-methyl-D-glucose as carbon source3MDG	D-saccharate as carbon sourceSAT	mucate as carbon sourceMUC	L-tartrate as carbon sourceLTAT	D-tartrate as carbon sourceDTAT	meso-tartrate as carbon sourceMTAT	D-malate as carbon sourceDMLT	L-malate as carbon sourceLMLT	cis-aconitate as carbon sourceCATE	trans-aconitate as carbon sourceTATE	tricarballylate as carbon sourceTTE	citrate as carbon sourceCIT	D-glucuronate as carbon sourceGRT	D-galacturonate as carbon sourceGAT	2-ketogluconate as carbon source2KG	5-ketogluconate as carbon source5KG	tryptophan as carbon sourceTRY	N-acetyl-D-glucosamine as carbon sourceNAG	D-gluconate as carbon sourceGNT	phenylacetate as carbon sourcePAC	protocatechuate as carbon sourcePAT	4-hydroxybenzoate as carbon sourcepOBE	quinate as carbon sourceQAT	gentisate as carbon sourceGTE	3-hydroxybenzoate as carbon sourcemOBE	benzoate as carbon sourceBAT	3-phenylpropionate as carbon sourcePPAT	m-coumarate as carbon sourceCMT	trigonelline as carbon sourceTGE	betaine as carbon sourceBET	putrescine as carbon sourcePCE	4-aminobutyrate as carbon sourceABT	histamine as carbon sourceHIN	DL-lactate as carbon sourceLAT	caprate as carbon sourceCAP	caprylate as carbon sourceCYT	L-histidine as carbon sourceHIS	succinate as carbon sourceSUC	fumarate as carbon sourceFUM	glutarate as carbon sourceGRE	DL-glycerate as carbon sourceGYT	5-aminovalerate as carbon sourceAVT	ethanolamine as carbon sourceETN	tryptamine as carbon sourceTTN	D-glucosamine as carbon sourceGLN	itaconate as carbon sourceITA	3-hydroxybutyrate as carbon source3OBU	L-aspartate as carbon sourceAPT	L-glutamate as carbon sourceGTT	L-proline as carbon sourcePRO	D-alanine as carbon sourceDALA	L-alanine as carbon sourceLALA	L-serine as carbon sourceSER	malonate as carbon sourceMNT	propionate as carbon sourcePROP	L-tyrosine as carbon sourceTYR	2-ketoglutarate as carbon source2KT
[Ref.: #116095]	3453	not determinedn.d.	+	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	+	-	-	-	-	+	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	+	+	+	-	+	-	-	+	-	-	+	+	-	+	+	+	+	-	+	-	-	-	+	+	+	+	+	+	+	-	+	+	+	+	+	+	-	-	+	+	+	+	+	+	+	+	+	+	+	+

API® zym:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Control	2-naphthyl phosphateAlkaline phosphatase	2-naphthyl butyrateEsterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	2-naphthyl myristateLipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	N-benzoyl-DL-arginine-2-naphthylamideTrypsin	N-glutaryl-phenylalanine-2-naphthylamidealpha- Chymotrypsin	2-naphthyl phosphateAcid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	6-Br-2-naphthyl-alphaD-galactpyranosidealpha- Galactosidase	2-naphthyl-betaD-galactpyranosidebeta- Galactosidase	Naphthol-AS-BI-betaD-glucuronidebeta- Glucuronidase	2-naphthyl-alphaD-glucopyranosidealpha- Glucosidase	6-Br-2-naphthyl-betaD-glucopyranosidebeta- Glucosidase	1-naphthyl-N-acetyl-betaD-glucosaminideN-acetyl-beta- glucosaminidase	6-Br-2-naphthyl-alphaD-mannopyranosidealpha- Mannosidase	2-naphthyl-alphaL-fucopyranosidealpha- Fucosidase
[Ref.: #116095]	13518	-	+	+	+	+	+	-	-	+	-	+	+	-	-	-	-	-	-	-	-

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #572]	Sample type/isolated from	outer ear infection

[Ref.: #47686]	Sample type/isolated from	Human outer ear infection

[Ref.: #67770]	Sample type/isolated from	Outer ear infection

[Ref.: #116095]	Sample type/isolated from	Human, Outer ear infection
[Ref.: #116095]	Geographic location (country and/or sea, region)	Oregon
[Ref.: #116095]	Country	United States of America
[Ref.: #116095]	Country ISO 3 Code	USA
[Ref.: #116095]	Continent	North America
[Ref.: #116095]	Isolation date	1943
* marker position based on {}

Isolation sources categories

#Infection	#Disease	-
#Host Body-Site	#Organ	#Ear

What are isolation sources categories?

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #572]	Pathogenicity (human)	yes
[Ref.: #572]	Pathogenicity (animal)	yes
[Ref.: #572]	Biosafety level	2	Risk group (German classification) According to TRBA 466
[Ref.: #116095]	Biosafety level	2	Risk group (French classification)

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #20218]	Pseudomonas aeruginosa strain DSM 1128 16S ribosomal RNA gene, partial sequence	AF502423	322	ENA	287 tax ID	*

Genome sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #66792]	Pseudomonas aeruginosa ATCC 9027	2645727823	draft	JGI IMG/M	287 tax ID	*
[Ref.: #66792]	Pseudomonas paraeruginosa ATCC 9027	GCA_002563335	contig	GenBank	2994495 tax ID	*
[Ref.: #66792]	Pseudomonas paraeruginosa ATCC 9027	GCA_001294675	contig	GenBank	2994495 tax ID	*
[Ref.: #66792]	Pseudomonas paraeruginosa ATCC 9027	GCA_001374975	contig	GenBank	2994495 tax ID	*
[Ref.: #66792]	Pseudomonas paraeruginosa ATCC 9027	GCA_001402955	scaffold	GenBank	2994495 tax ID	*
[Ref.: #66792]	Pseudomonas aeruginosa strain ATCC 9027	287.1969	wgs	PATRIC	287 tax ID	*

Data predicted using genome information as a basis Genome-based predictions

	Trait	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Pseudomonas aeruginosa ATCC 9027 NCBI: GCA_001402955.1
[Ref.: #69481]	spore-forming	no	100	no

	Trait	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Pseudomonas aeruginosa ATCC 9027 NCBI: GCA_002601815.1
[Ref.: #69480]	flagellated	yes	84.798	no
[Ref.: #69480]	gram-positive	no	98.434	no
[Ref.: #69480]	anaerobic	no	98.527	no
[Ref.: #69480]	aerobic	yes	92.947	no
[Ref.: #69480]	halophile	no	93.108	no
[Ref.: #69480]	spore-forming	no	92.719	no
[Ref.: #69480]	glucose-util	yes	92.772	no
[Ref.: #69480]	thermophile	no	99.764	yes
[Ref.: #69480]	motile	yes	90.15	no
[Ref.: #69480]	glucose-ferment	no	89.789	no

Availability in culture collections External links

[Ref.: #572]

Culture collection no.

DSM 1128, ATCC 9027, CIP 82.118, DSM 1385, WDCM 00026, CCUG 22801, CCM 1961, IAM 10374, IFO 13275, JCM 23217, BUCSAV 278, IAM 13074, JCM 14171, NBRC 13275, NCIMB 8626, NRRL B-800, CIP 72.26, IMET 10905, NCTC 12924, CECT 111, LMG 8029, CMCC (B) 10104

[Ref.: #81969]

SI-ID 3893

Literature:

Only first 10 entries are displayed. Click here to see all.

Topic	Title	Authors	Journal	DOI	Year
Cultivation	GVPC Medium Manufactured without Oxygen Improves the Growth of Legionella spp. and Exhibits Enhanced Selectivity Properties.	Casino P, Lopez A, Peiro S, Rios M, Rios S, Porta A, Agusti G, Asensio D, Marques AM, Pique N	Microbiol Spectr	10.1128/spectrum.02401-21	2022	*
Phylogeny	Biosynthesis of Selenium Nanoparticles (via Bacillus subtilis BSN313), and Their Isolation, Characterization, and Bioactivities.	Ullah A, Yin X, Wang F, Xu B, Mirani ZA, Xu B, Chan MWH, Ali A, Usman M, Ali N, Naveed M	Molecules	10.3390/molecules26185559	2021	*
Metabolism	PqsR-independent quorum-sensing response of Pseudomonas aeruginosa ATCC 9027 outlier-strain reveals new insights on the PqsE effect on RhlR activity.	Garcia-Reyes S, Cocotl-Yanez M, Soto-Aceves MP, Gonzalez-Valdez A, Servin-Gonzalez L, Soberon-Chavez G	Mol Microbiol	10.1111/mmi.14797	2021	*
Pathogenicity	Rational Design of Dipicolylamine-Containing Carbazole Amphiphiles Combined with Zn(2+) as Potent Broad-Spectrum Antibacterial Agents with a Membrane-Disruptive Mechanism.	Liu J, Li H, Li H, Fang S, Shi J, Chen Y, Zhong R, Liu S, Lin S	J Med Chem	10.1021/acs.jmedchem.1c00858	2021	*
Pathogenicity	Anti-Pseudomonas aeruginosa biofilm activity of tellurium nanorods biosynthesized by cell lysate of Haloferax alexandrinus GUSF-1(KF796625).	Alvares JJ, Furtado IJ	Biometals	10.1007/s10534-021-00323-y	2021	*
Pathogenicity	Semi-synthesis of N-alkyl-kappa-carrageenan derivatives and evaluation of their antibacterial activity.	Junior EH, Goncalves AG, Noseda MD, Duarte MER, Murakami FS, Ducatti DRB	Carbohydr Res	10.1016/j.carres.2021.108234	2021	*
Pathogenicity	Biomedical Applications of Mycosynthesized Selenium Nanoparticles Using Penicillium expansum ATTC 36200.	Hashem AH, Khalil AMA, Reyad AM, Salem SS	Biol Trace Elem Res	10.1007/s12011-020-02506-z	2021	*
Pathogenicity	Antimicrobial and Antibiofilm Activity of Lys-[Trp6]hy-a1 Combined with Ciprofloxacin Against Gram-Negative Bacteria.	Carneiro VA, de Oliveira ST, Silva RL, de Sousa Duarte H, Silva ML, Matos MNC, Cavalcante RMB, Figueira CS, Lorenzon EN, Cilli EM, da Cunha RMS	Protein Pept Lett	10.2174/0929866527666200416145549	2020	*
Pathogenicity	Synthesis of novel 2, 3, 5-tri-substituted thiazoles with anti-inflammatory and antibacterial effect causing clinical pathogens.	Ahmed A, Molvi KI, Patel HM, Ullah R, Bari A	J Infect Public Health	10.1016/j.jiph.2020.02.002	2020	*
Metabolism	Enhancement of Antibacterial Activity of Paludifilum halophilum and Identification of N-(1-Carboxy-ethyl)-phthalamic Acid as the Main Bioactive Compound.	Frikha-Dammak D, Fakhfakh J, Belhaj D, Bouattour E, Ayadi H, Chaabouni M, Ayadi H, Maalej S	Biomed Res Int	10.1155/2020/4805706	2020	*
Pathogenicity	Imaging studies of bacterial biofilms on cochlear implants-Bioactive glass (BAG) inhibits mature biofilm.	Kirchhoff L, Arweiler-Harbeck D, Arnolds J, Hussain T, Hansen S, Bertram R, Buer J, Lang S, Steinmann J, Hoing B	PLoS One	10.1371/journal.pone.0229198	2020	*
Pathogenicity	Antimicrobial Effectiveness in Eye Drops: Limited Sterility versus Reduction in Microbial Count.	Abu Shaqra QM, Al-Groom RM, Abu Shaqra AQ	PDA J Pharm Sci Technol	10.5731/pdajpst.2019.009845	2020	*
Metabolism	Rapid and solitary production of mono-rhamnolipid biosurfactant and biofilm inhibiting pyocyanin by a taxonomic outlier Pseudomonas aeruginosa strain CR1.	Sood U, Singh DN, Hira P, Lee JK, Kalia VC, Lal R, Shakarad M	J Biotechnol	10.1016/j.jbiotec.2019.11.004	2019	*
Metabolism	Functional roles of norCB in Pseudomonas aeruginosa ATCC 9027 under aerobic conditions.	Zhou G, Wang YS, Peng H, Shen PF, Xie XB, Shi QS	J Basic Microbiol	10.1002/jobm.201900267	2019	*
Enzymology	Biological functions of nirS in Pseudomonas aeruginosa ATCC 9027 under aerobic conditions.	Zhou G, Peng H, Wang YS, Li CL, Shen PF, Huang XM, Xie XB, Shi QS	J Ind Microbiol Biotechnol	10.1007/s10295-019-02232-z	2019	*
Pathogenicity	Colorimetric microdilution assay: Validation of a standard method for determination of MIC, IC50%, and IC90% of antimicrobial compounds.	Veiga A, Toledo MDGT, Rossa LS, Mengarda M, Stofella NCF, Oliveira LJ, Goncalves AG, Murakami FS	J Microbiol Methods	10.1016/j.mimet.2019.05.003	2019	*
Pathogenicity	Chemical Composition and Antimicrobial Activity of Laurus nobilis L. Essential Oils from Bulgaria.	Fidan H, Stefanova G, Kostova I, Stankov S, Damyanova S, Stoyanova A, Zheljazkov VD	Molecules	10.3390/molecules24040804	2019	*
Pathogenicity	Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study.	Mangiaterra G, Amiri M, Di Cesare A, Pasquaroli S, Manso E, Cirilli N, Citterio B, Vignaroli C, Biavasco F	BMC Infect Dis	10.1186/s12879-018-3612-9	2018	*
Pathogenicity	N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.	Asadipour A, Moshafi MH, Khosravani L, Moghimi S, Amou E, Firoozpour L, Ilbeigi G, Beiki K, Soleimani E, Foroumadi A	Daru	10.1007/s40199-018-0226-0	2018	*
Metabolism	Overproduction of rhamnolipids in Pseudomonas aeruginosa PA14 by redirection of the carbon flux from polyhydroxyalkanoate synthesis and overexpression of the rhlAB-R operon.	Gutierrez-Gomez U, Soto-Aceves MP, Servin-Gonzalez L, Soberon-Chavez G	Biotechnol Lett	10.1007/s10529-018-2610-8	2018	*
Pathogenicity	Experimental approach for a possible integrated protocol to determine sanitizer activity against both planktonic bacteria and related biofilms.	Campana R, Ciandrini E, Baffone W	Food Res Int	10.1016/j.foodres.2018.05.067	2018	*
Genetics	Draft Genome Sequence of Pseudomonas aeruginosa ATCC 9027, Originally Isolated from an Outer Ear Infection.	Jayal A, Johns BE, Purdy KJ, Maddocks SE	Genome Announc	10.1128/genomeA.01397-17	2017	*
Pathogenicity	Inhibition of bacterial biofilms by carboxymethyl chitosan combined with silver, zinc and copper salts.	Goncalves RC, da Silva DP, Signini R, Naves PLF	Int J Biol Macromol	10.1016/j.ijbiomac.2017.07.048	2017	*
Pathogenicity	In Vitro Evaluation of the Antioxidant, Cytoprotective, and Antimicrobial Properties of Essential Oil from Pistacia vera L. Variety Bronte Hull.	Smeriglio A, Denaro M, Barreca D, Calderaro A, Bisignano C, Ginestra G, Bellocco E, Trombetta D	Int J Mol Sci	10.3390/ijms18061212	2017	*
Metabolism	A deletion mutation in nfxB of in vitro-induced moxifloxacin-resistant Pseudomonas aeruginosa confers multidrug resistance.	Thai VC, Pham HV, Nguyen DNM, Lambert P, Nguyen TTH	Acta Microbiol Immunol Hung	10.1556/030.64.2017.012	2017	*
Pathogenicity	Efficacy of benzalkonium chloride against bioluminescent P. aeruginosa ATCC9027 constructs.	Shah N, Naseby DC	Biosens Bioelectron	10.1016/j.bios.2017.04.029	2017	*
Pathogenicity	Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo Dragon) by Large-Scale Analyses and De-Novo-Assisted Sequencing Using Electron-Transfer Dissociation Mass Spectrometry.	Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML	J Proteome Res	10.1021/acs.jproteome.6b00857	2017	*
Metabolism	Effect of rhamnolipid solubilization on hexadecane bioavailability: enhancement or reduction?	Liu Y, Zeng G, Zhong H, Wang Z, Liu Z, Cheng M, Liu G, Yang X, Liu S	J Hazard Mater	10.1016/j.jhazmat.2016.10.025	2016	*
Pathogenicity	A bioactivity guided study on the antibacterial activity of Hertia cheirifolia L. extracts.	Majouli K, Hamdi A, Msaada K, Kenani A	Microb Pathog	10.1016/j.micpath.2016.10.015	2016	*
Metabolism	Pseudomonas aeruginosa ATCC 9027 is a non-virulent strain suitable for mono-rhamnolipids production.	Grosso-Becerra MV, Gonzalez-Valdez A, Granados-Martinez MJ, Morales E, Servin-Gonzalez L, Mendez JL, Delgado G, Morales-Espinosa R, Ponce-Soto GY, Cocotl-Yanez M, Soberon-Chavez G	Appl Microbiol Biotechnol	10.1007/s00253-016-7789-9	2016	*
Pathogenicity	Antimicrobial evaluation of selected naturally occurring oxyprenylated secondary metabolites.	Di Giulio M, Genovese S, Fiorito S, Epifano F, Nostro A, Cellini L	Nat Prod Res	10.1080/14786419.2015.1079908	2015	*
Pathogenicity	A bactericidal calix[4]arene-based nanoconstruct with amplified NO photorelease.	Di Bari I, Picciotto R, Granata G, Blanco AR, Consoli GM, Sortino S	Org Biomol Chem	10.1039/c6ob01305h	2016	*
Pathogenicity	Modulation of antibiotic resistance in Pseudomonas aeruginosa by ZnO nanoparticles.	Bayroodi E, Jalal R	Iran J Microbiol		2016	*
Pathogenicity	Effect of Mono and Di-rhamnolipids on Biofilms Pre-formed by Bacillus subtilis BBK006.	De Rienzo MA, Martin PJ	Curr Microbiol	10.1007/s00284-016-1046-4	2016	*
Pathogenicity	A novel approach to antibiofilm susceptibility testing using a thermo-reversible matrix.	Taylor BJ, Marsh LL, Nosworthy JO, Williams DW	J Wound Care	10.12968/jowc.2016.25.2.62	2016	*
Pathogenicity	Effect of low-concentration rhamnolipid on transport of Pseudomonas aeruginosa ATCC 9027 in an ideal porous medium with hydrophilic or hydrophobic surfaces.	Zhong H, Liu G, Jiang Y, Brusseau ML, Liu Z, Liu Y, Zeng G	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2015.11.024	2015	*
Pathogenicity	Inhibitory Effects of 2,2'-Dipyridyl and 1,2,3,4,6-Penta-O-Galloyl-b-D-Glucopyranose on Biofilm Formation in Contact Lens Cases.	Cho P, Shi GS, Boost M	Invest Ophthalmol Vis Sci	10.1167/iovs.15-17723	2015	*
Genetics	Draft Genome Sequence of Pseudomonas aeruginosa ATCC 9027 (DSM 1128), an Important Rhamnolipid Surfactant Producer and Sterility Testing Strain.	Mai-Prochnow A, Bradbury M, Murphy AB	Genome Announc	10.1128/genomeA.01259-15	2015	*
Metabolism	Biosurfactant production by Pseudomonas aeruginosain kefir and fish meal.	Kaskatepe B, Yildiz S, Gumustas M, Ozkan SA	Braz J Microbiol	10.1590/S1517-838246320140727	2015	*
Enzymology	Microbial spoilage, instability risk of antacid suspension in the presence of commonly used preservative system.	Khan JA, Khan IU, Iqbal Z, Nasir F, Muhammad S, Hannan PA, Ullah I	Pak J Pharm Sci		2015	*
Pathogenicity	Identification of an antibacterial protein by functional screening of a human oral metagenomic library.	Arivaradarajan P, Warburton PJ, Paramasamy G, Nair SP, Allan E, Mullany P	FEMS Microbiol Lett	10.1093/femsle/fnv142	2015	*
Pathogenicity	Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles.	Mavrova ATs, Yancheva D, Anastassova N, Anichina K, Zvezdanovic J, Djordjevic A, Markovic D, Smelcerovic A	Bioorg Med Chem	10.1016/j.bmc.2015.08.029	2015	*
Enzymology	Rapid identification of Pseudomonas aeruginosa by pulsed-field gel electrophoresis.	Selim S, El Kholy I, Hagagy N, El Alfay S, Aziz MA	Biotechnol Biotechnol Equip	10.1080/13102818.2014.981065	2014	*
Metabolism	Effects of biosurfactant-producing bacteria on biodegradation and transport of phenanthrene in subsurface soil.	Chang JS, Cha DK, Radosevich M, Jin Y	J Environ Sci Health A Tox Hazard Subst Environ Eng	10.1080/10934529.2015.994967	2015	*
Pathogenicity	Expression of recombinant Arabian camel lactoferricin-related peptide in Pichia pastoris and its antimicrobial identification.	Chahardooli M, Niazi A, Aram F, Sohrabi SM	J Sci Food Agric	10.1002/jsfa.7125	2015	*
Enzymology	Validation of constitutively expressed bioluminescent Pseudomonas aeruginosa as a rapid microbiological quantification tool.	Shah N, Naseby DC	Biosens Bioelectron	10.1016/j.bios.2015.01.008	2015	*
Metabolism	Effect of low-concentration rhamnolipid on adsorption of Pseudomonas aeruginosa ATCC 9027 on hydrophilic and hydrophobic surfaces.	Zhong H, Jiang Y, Zeng G, Liu Z, Liu L, Liu Y, Yang X, Lai M, He Y	J Hazard Mater	10.1016/j.jhazmat.2014.11.050	2014	*
Proteome	Insights into Pseudomonas aeruginosa ATCC9027 resistance to isothiazolones through proteomics.	Zhou G, Shi QS, Huang XM, Xie XB, Chen YB	Microb Drug Resist	10.1089/mdr.2014.0113	2014	*
Biotechnology	Assessment of tolerance induction by Origanum vulgare L. essential oil or carvacrol in Pseudomonas aeruginosa cultivated in a meat-based broth and in a meat model.	da Silva Luz I, Gomes-Neto NJ, Magnani M, de Souza EL	Food Sci Technol Int	10.1177/1082013214554467	2014	*
Pathogenicity	Manuka honey treatment of biofilms of Pseudomonas aeruginosa results in the emergence of isolates with increased honey resistance.	Camplin AL, Maddocks SE	Ann Clin Microbiol Antimicrob	10.1186/1476-0711-13-19	2014	*
Metabolism	Statistical screening of medium components for recombinant production of Pseudomonas aeruginosa ATCC 9027 rhamnolipids by nonpathogenic cell factory Pseudomonas putida KT2440.	Setoodeh P, Jahanmiri A, Eslamloueyan R, Niazi A, Ayatollahi SS, Aram F, Mahmoodi M, Hortamani A	Mol Biotechnol	10.1007/s12033-013-9693-1	2014	*
Pathogenicity	Cis-9-octadecenoic acid from the rhizospheric bacterium Stenotrophomonas maltophilia BJ01 shows quorum quenching and anti-biofilm activities.	Singh VK, Kavita K, Prabhakaran R, Jha B	Biofouling	10.1080/08927014.2013.807914	2013	*
Metabolism	Use of a greasy effluent floater treatment station from the slaughterhouse for biosurfactant production.	Borges Wda S, Cardoso VL, de Resende MM	Biotechnol Appl Biochem	10.1002/bab.1018	2012	*
Metabolism	Biochemical characterization and evaluation of potent inhibitors of the Pseudomonas aeruginosa PA01 acetohydroxyacid synthase.	Cho JH, Lee MY, Baig IA, Ha NR, Kim J, Yoon MY	Biochimie	10.1016/j.biochi.2013.03.007	2013	*
Pathogenicity	Antimicrobial activity of blended essential oil preparation.	Tadtong S, Suppawat S, Tintawee A, Saramas P, Jareonvong S, Hongratanaworakit T	Nat Prod Commun		2012	*
Pathogenicity	In-vivo and in-vitro biocompatibility evaluations of silver nanoparticles with antimicrobial activity.	Han DW, Woo YI, Lee MH, Lee JH, Lee J, Park JC	J Nanosci Nanotechnol	10.1166/jnn.2012.6367	2012	*
Pathogenicity	Synthesis and characterization of some new complexes of Cu(II), Ni(II) and V(IV) with Schiff base derived from indole-3-carboxaldehyde. Biological activity on prokaryotes and eukaryotes.	Rosu T, Pahontu E, Ilies DC, Georgescu R, Mocanu M, Leabu M, Shova S, Gulea A	Eur J Med Chem	10.1016/j.ejmech.2012.03.046	2012	*
Pathogenicity	Semisynthesis and antimicrobial activity of novel guttiferone-A derivatives.	Dias KS, Januario JP, D' Dego JL, Dias AL, dos Santos MH, Camps I, Coelho LF, Viegas C Jr	Bioorg Med Chem	10.1016/j.bmc.2012.02.023	2012	*
Pathogenicity	Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7.	Morita Y, Tomida J, Kawamura Y	Microbiology (Reading)	10.1099/mic.0.054320-0	2012	*
Pathogenicity	Contact lens disinfecting solutions antibacterial efficacy: comparison between clinical isolates and the standard ISO ATCC strains of Pseudomonas aeruginosa and Staphylococcus aureus.	Mohammadinia M, Rahmani S, Eslami G, Ghassemi-Broumand M, Aghazadh Amiri M, Aghaie G, Tabatabaee SM, Taheri S, Behgozin A	Eye (Lond)	10.1038/eye.2011.284	2011	*
Pathogenicity	In vitro assay of the antimicrobial activity of kephir against bacterial and fungal strains.	Chifiriuc MC, Cioaca AB, Lazar V	Anaerobe	10.1016/j.anaerobe.2011.04.020	2011	*
Pathogenicity	Importance of rub and rinse in use of multipurpose contact lens solution.	Zhu H, Bandara MB, Vijay AK, Masoudi S, Wu D, Willcox MD	Optom Vis Sci	10.1097/OPX.0b013e31821bf976	2011	*
Pathogenicity	The influence of nanoscopically thin silver films on bacterial viability and attachment.	Ivanova EP, Hasan J, Truong VK, Wang JY, Raveggi M, Fluke C, Crawford RJ	Appl Microbiol Biotechnol	10.1007/s00253-011-3195-5	2011	*
Pathogenicity	Hydroalcoholic extract based-ointment from Punica granatum L. peels with enhanced in vivo healing potential on dermal wounds.	Hayouni EA, Miled K, Boubaker S, Bellasfar Z, Abedrabba M, Iwaski H, Oku H, Matsui T, Limam F, Hamdi M	Phytomedicine	10.1016/j.phymed.2011.02.011	2011	*
Pathogenicity	Comparative efficacies of contact lens disinfecting solutions against Pseudomonas aeruginosa.	Amiri MA, Mohammadinia M, Tabatabaee M, Askarizadeh F, Behgozin A	Clin Exp Optom	10.1111/j.1444-0938.2010.00576.x	2011	*
Metabolism	Effects of rhamnolipids on cell surface hydrophobicity of PAH degrading bacteria and the biodegradation of phenanthrene.	Zhao Z, Selvam A, Wong JW	Bioresour Technol	10.1016/j.biortech.2010.11.088	2010	*
Pathogenicity	P(4-VP) based nanoparticles and composites with dual action as antimicrobial materials.	Ozay O, Akcali A, Otkun MT, Silan C, Aktas N, Sahiner N	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2010.05.013	2010	*
Pathogenicity	Antimicrobial and antioxidant activities of Mexican oregano essential oils (Lippia graveolens H. B. K.) with different composition when microencapsulated in beta-cyclodextrin.	Arana-Sanchez A, Estarron-Espinosa M, Obledo-Vazquez EN, Padilla-Camberos E, Silva-Vazquez R, Lugo-Cervantes E	Lett Appl Microbiol	10.1111/j.1472-765X.2010.02837.x	2010	*
Pathogenicity	New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.	Almajan GL, Barbuceanu SF, Saramet I, Draghici C	Eur J Med Chem	10.1016/j.ejmech.2010.02.057	2010	*
Genetics	Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7.	Roy PH, Tetu SG, Larouche A, Elbourne L, Tremblay S, Ren Q, Dodson R, Harkins D, Shay R, Watkins K, Mahamoud Y, Paulsen IT	PLoS One	10.1371/journal.pone.0008842	2010	*
Pathogenicity	In vitro synergistic activities of essential oils and surfactants in combination with cosmetic preservatives against Pseudomonas aeruginosa and Staphylococcus aureus.	Patrone V, Campana R, Vittoria E, Baffone W	Curr Microbiol	10.1007/s00284-009-9531-7	2009	*
Pathogenicity	Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.	Barbuceanu SF, Almajan GL, Saramet I, Draghici C, Tarcomnicu AI, Bancescu G	Eur J Med Chem	10.1016/j.ejmech.2009.06.021	2009	*
Pathogenicity	Antimicrobial activity of lavender, tea tree and lemon oils in cosmetic preservative systems.	Kunicka-Styczynska A, Sikora M, Kalemba D	J Appl Microbiol	10.1111/j.1365-2672.2009.04372.x	2009	*
Pathogenicity	Copper(II) and uranyl(II) complexes with acylthiosemicarbazide: synthesis, characterization, antibacterial activity and effects on the growth of promyelocytic leukemia cells HL-60.	Angelusiu MV, Almajan GL, Rosu T, Negoiu M, Almajan ER, Roy J	Eur J Med Chem	10.1016/j.ejmech.2009.03.016	2009	*
Enzymology	[Microbiological contamination and antimicrobial activity of cristalised cane sugar on some medically important microorganisms in Costa Rica].	Pujol V, Diaz J, Rodriguez E, Arias ML	Rev Biol Trop		2008	*
Pathogenicity	Synthesis, characterization and antibacterial activity of some triazole Mannich bases carrying diphenylsulfone moieties.	Almajan GL, Barbuceanu SF, Almajan ER, Draghici C, Saramet G	Eur J Med Chem	10.1016/j.ejmech.2008.07.003	2008	*
Pathogenicity	Novel lipid and preservative-free propofol formulation: properties and pharmacodynamics.	Ravenelle F, Gori S, Le Garrec D, Lessard D, Luo L, Palusova D, Sneyd JR, Smith D	Pharm Res	10.1007/s11095-007-9471-5	2007	*
Metabolism	Production and characterization of polyhydroxyalkanoates in Pseudomonas aeruginosa ATCC 9027 from glucose, an unrelated carbon source.	Rojas-Rosas O, Villafana-Rojas J, Lopez-Dellamary FA, Nungaray-Arellano J, Gonzalez-Reynoso O	Can J Microbiol	10.1139/W07-023	2007	*
Pathogenicity	[Investigation of the efficacy of electrolyzed acid water on the standard strains of some pathogenic microorganisms].	Ileri C, Sezen Y, Dimoglo A	Mikrobiyol Bul		2006	*
Enzymology	Determination of the acid dissociation constant of the biosurfactant monorhamnolipid in aqueous solution by potentiometric and spectroscopic methods.	Lebron-Paler A, Pemberton JE, Becker BA, Otto WH, Larive CK, Maier RM	Anal Chem	10.1021/ac0608826	2006	*
Enzymology	Enhanced aqueous solubilization of tetrachloroethylene by a rhamnolipid biosurfactant.	Clifford JS, Ioannidis MA, Legge RL	J Colloid Interface Sci	10.1016/j.jcis.2006.10.026	2006	*
Pathogenicity	[Microbiological assessment of efficiency of antibacterial modified textiles].	Jakimiak B, Rohm-Rodowald E, Staniszewska M, Cieslak M, Malinowska G, Kaleta A	Rocz Panstw Zakl Hig		2006	*
Pathogenicity	Microbiological study of cosmetic products during their use by consumers: health risk and efficacy of preservative systems.	Campana R, Scesa C, Patrone V, Vittoria E, Baffone W	Lett Appl Microbiol	10.1111/j.1472-765X.2006.01952.x	2006	*
Enzymology	Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.	Chan E, Zhou S, Srikumar S, Duan W	Pharm Res	10.1007/s11095-006-9783-x	2006	*
Pathogenicity	Antimicrobial preservative effectiveness of natural peptide antibiotics.	Kamysz W, Turecka K	Acta Pol Pharm		2005	*
Biotechnology	[Evaluation of the antimicrobial action of honey against Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia coli, Salmonella enteritidis, Listeria monocytogenes and Aspergillus niger. Evaluation of its microbiological charge].	Estrada H, Gamboa Mdel M, Arias ML, Chaves C	Arch Latinoam Nutr		2005	*
Metabolism	Monitoring microaerobic denitrification of Pseudomonas aeruginosa by online NAD(P)H fluorescence.	Ju LK, Chen F, Xia Q	J Ind Microbiol Biotechnol	10.1007/s10295-005-0035-6	2005	*
Pathogenicity	Allylthiosulfinate: beta-cyclodextrin inclusion complex: preparation, characterization and microbiological activity.	Nikolic V, Stankovic M, Kapor A, Nikolic Lj, Cvetkovic D, Stamenkovic J	Pharmazie		2004	*
Enzymology	Solubilization and desorption of PAHs in soil-aqueous system by biosurfactants produced from Pseudomonas aeruginosa P-CG3 under thermophilic condition.	Cheng KY, Zhao ZY, Wong JW	Environ Technol	10.1080/09593332508618382	2004	*
Metabolism	Effect of surfactants on solubilization and degradation of phenanthrene under thermophilic conditions.	Wong JW, Fang M, Zhao Z, Xing B	J Environ Qual	10.2134/jeq2004.2015	2004	*
Enzymology	Cadmium removal from contaminated soil by tunable biopolymers.	Prabhukumar G, Matsumoto M, Mulchandani A, Chen W	Environ Sci Technol	10.1021/es035150z	2004	*
Pathogenicity	Preliminary evaluation of bioactive glass S53P4 as an endodontic medication in vitro.	Zehnder M, Soderling E, Salonen J, Waltimo T	J Endod	10.1097/00004770-200404000-00009	2004	*
Metabolism	Structure and characterization of flavolipids, a novel class of biosurfactants produced by Flavobacterium sp. strain MTN11.	Bodour AA, Guerrero-Barajas C, Jiorle BV, Malcomson ME, Paull AK, Somogyi A, Trinh LN, Bates RB, Maier RM	Appl Environ Microbiol	10.1128/AEM.70.1.114-120.2004	2004	*
Metabolism	Aerobic denitrification of Pseudomonas aeruginosa monitored by online NAD(P)H fluorescence.	Chen F, Xia Q, Ju LK	Appl Environ Microbiol	10.1128/AEM.69.11.6715-6722.2003	2003	*
Pathogenicity	Antibacterial activity of intraocularly used liquids against two strains of Pseudomonas aeruginosa.	Economou-Stamatelopoulou C, Roussopoulos GP, Prouskas JC, Apostolopoulos M	Ophthalmologica	10.1159/000073074	2003	*
Metabolism	Phenanthrene degradation in soils co-inoculated with phenanthrene-degrading and biosurfactant-producing bacteria.	Dean SM, Jin Y, Cha DK, Wilson SV, Radosevich M	J Environ Qual	10.2134/jeq2001.3041126x	2001	*
Pathogenicity	Comparative responses of Pseudomonas stutzeri and Pseudomonas aeruginosa to antibacterial agents.	Tattawasart U, Maillard JY, Furr JR, Russell AD	J Appl Microbiol	10.1046/j.1365-2672.1999.00811.x	1999	*
Pathogenicity	Electron-microscopic study of the bactericidal effect of OPB-2045, a new mono-biguanide disinfectant produced from biguanide group compounds, against Pseudomonas aeruginosa.	Sakagami Y, Mimura M, Kajimura K, Yokoyama H, Nishimura H	J Pharm Pharmacol	10.1211/0022357991772141	1999	*
Genetics	Structural and functional implications of sequence diversity of Pseudomonas aeruginosa genes oriC, ampC and fliC.	Spangenberg C, Montie TC, Tummler B	Electrophoresis	10.1002/elps.1150190414	1998	*
Metabolism	Evaluation of the biological containment system based on the Escherichia coli gef gene in Pseudomonas aeruginosa W51D.	Soberon-Chavez G	Appl Microbiol Biotechnol	10.1007/s002530050859	1996	*
Enzymology	Biosurfactant-facilitated remediation of metal-contaminated soils.	Miller RM	Environ Health Perspect	10.1289/ehp.95103s159	1995	*
Metabolism	Enhanced octadecane dispersion and biodegradation by a Pseudomonas rhamnolipid surfactant (biosurfactant).	Zhang Y, Miller RM	Appl Environ Microbiol	10.1128/aem.58.10.3276-3282.1992	1992	*
Biotechnology	[Microbial growth in parenteral nutrition. II. Effects of osmolality].	Vilchez Medina T, Montero Herrero CG, Garcia Curiel A, Lluch Colomer A, Rodriguez Cobacho A, Atienza Fernandez M	Nutr Hosp		1990	*
Enzymology	[A microbial growth study in parenteral nutrition].	Vilchez Medina T, Montero Herrero CG, Garcia Curiel A, Atienza Fernandez M	Nutr Hosp		1989	*
Metabolism	Amikacin disrupts the cell envelope of Pseudomonas aeruginosa ATCC 9027.	Walker SG, Beveridge TJ	Can J Microbiol	10.1139/m88-003	1988	*
Pathogenicity	Gentamicin interaction with Pseudomonas aeruginosa cell envelope.	Martin NL, Beveridge TJ	Antimicrob Agents Chemother	10.1128/AAC.29.6.1079	1986	*
Metabolism	Lipopolysaccharide changes and cytoplasmic polyphosphate granule accumulation in Pseudomonas aeruginosa during growth on hexadecane.	Miguez CB, Beveridge TJ, Ingram JM	Can J Microbiol	10.1139/m86-049	1986	*
Phylogeny	Spectral properties of a mixture of fluorescent pigments produced by Pseudomonas aeruginosa.	MacDonald JC, Bishop GG	Biochim Biophys Acta	10.1016/0304-4165(84)90088-6	1984	*
Phylogeny	Isolation of a Pseudomonas sp. Which Utilizes the Phosphonate Herbicide Glyphosate.	Moore JK, Braymer HD, Larson AD	Appl Environ Microbiol	10.1128/aem.46.2.316-320.1983	1983	*
Enzymology	Glycogen and various other polysaccharides stimulate the formation of exolipase by Pseudomonas aeruginosa.	Schulte G, Bohne L, Winkler U	Can J Microbiol	10.1139/m82-095	1982	*
Metabolism	Penetration of the outer membrane of Pseudomonas aeruginosa by synergistic combinations of beta-lactam and aminoglycoside antibiotics.	Scudamore RA, Goldner M	Antimicrob Agents Chemother	10.1128/AAC.21.6.1007	1982	*
Metabolism	Limited contribution of the outer-membrane penetration barrier towards intrinsic antibiotic resistance of Pseudomonas aeruginosa.	Scudamore RA, Goldner M	Can J Microbiol	10.1139/m82-022	1982	*
Enzymology	Heterogeneity and distribution of lipopolysaccharide in the cell wall of a gram-negative marine bacterium.	DiRienzo JM, Deneke CF, MacLeod RA	J Bacteriol	10.1128/jb.136.1.148-157.1978	1978	*
Metabolism	The release and characterization of some periplasm-located enzymes of Pseudomona aeruginosa.	Bhatti AR, DeVoe IW, Ingram JM	Can J Microbiol	10.1139/m76-211	1976	*
Pathogenicity	Reduced virulence of Pseudomonas aeruginosa grown in the presence of benzalkonium chloride.	Adair FW, Liauw HL, Geftic SG, Gelzer J	J Clin Microbiol	10.1128/jcm.1.2.175-179.1975	1975	*
Cultivation	Release of alkaline phosphatase from cells of Pseudomonas aeruginosa by manipulation of cation concentration and of pH.	Cheng KJ, Ingram JM, Costerton JW	J Bacteriol	10.1128/jb.104.2.748-753.1970	1970	*
Metabolism	Amino acid pool formation in Pseudomonas aeruginosa.	Kay WW, Gronlund AF	J Bacteriol	10.1128/jb.97.1.282-291.1969	1969	*
Phylogeny	Larval gut microbiome of Pelidnota luridipes (Coleoptera: Scarabaeidae): high bacterial diversity, different metabolic profiles on gut chambers and species with probiotic potential.	Falqueto SA, de Sousa JR, da Silva RC, da Silva GF, Pinheiro DG, Soares MA	World J Microbiol Biotechnol	10.1007/s11274-022-03387-1	2022	*
Pathogenicity	Design, synthesis, and biological evaluation of tetrahydroquinoline amphiphiles as membrane-targeting antimicrobials against pathogenic bacteria and fungi.	Liu J, Li H, He Q, Chen K, Chen Y, Zhong R, Li H, Fang S, Liu S, Lin S	Eur J Med Chem	10.1016/j.ejmech.2022.114734	2022	*
	Antimicrobial potential of natural deep eutectic solvents.	Al-Akayleh F, Khalid RM, Hawash D, Al-Kaissi E, Al-Adham ISI, Al-Muhtaseb N, Jaber N, Al-Remawi M, Collier PJ	Lett Appl Microbiol	10.1111/lam.13699	2022	*
	Removal of heavy oil from contaminated surfaces with a detergent formulation containing biosurfactants produced by Pseudomonas spp.	Farias CBB, Soares da Silva RCF, Almeida FCG, Santos VA, Sarubbo LA	PeerJ	10.7717/peerj.12518	2021	*
	Chemical Profile of the Volatile Constituents and Antimicrobial Activity of the Essential Oils from Croton adipatus, Croton thurifer, and Croton collinus.	Cucho-Medrano JLL, Mendoza-Beingolea SW, Fuertes-Ruiton CM, Salazar-Salvatierra ME, Herrera-Calderon O	Antibiotics (Basel)	10.3390/antibiotics10111387	2021	*
	Essential Oil and Hydrophilic Antibiotic Co-Encapsulation in Multiple Lipid Nanoparticles: Proof of Concept and In Vitro Activity against Pseudomonas aeruginosa.	Ben-Khalifa R, Gaspar FB, Pereira C, Chekir-Ghedira L, Rodriguez-Rojo S	Antibiotics (Basel)	10.3390/antibiotics10111300	2021	*
	Behavior of Pseudomonas aeruginosa strains on the nanopillar topography of dragonfly (Pantala flavescens) wing under flow conditions.	Kamarajan BP, Ananthasubramanian M, Sriramajayam L, Boppe A	Biointerphases	10.1116/6.0001303	2021	*
	Vfr or CyaB promote the expression of the pore-forming toxin exlBA operon in Pseudomonas aeruginosa ATCC 9027 without increasing its virulence in mice.	Garcia-Reyes S, Moustafa DA, Attree I, Goldberg JB, Quiroz-Morales SE, Soberon-Chavez G	Microbiology (Reading)	10.1099/mic.0.001083	2021	*
	The Autofluorescence Patterns of Acanthamoeba castellanii, Pseudomonas aeruginosa and Staphylococcus aureus: Effects of Antibiotics and Tetracaine.	Peguda HK, Mahbub SB, Sherpa TD, Subedi D, Habibalahi A, Anwer AG, Gu Z, Willcox MDP, Goldys EM, Carnt NA	Pathogens	10.3390/pathogens10070894	2021	*
	Determination of the Chemical Composition and Antimicrobial Activity of Lavatera thuringiaca L. Medicinal Herb Material Extracted under Subcritical Conditions by the Liquid Carbon Dioxide Method.	Zhandabayeva MA, Kozhanova KK, Boshkayeva AK, Kataev VA, Ustenova GO, Gemejiyeva NG, Iskakbayeva ZA	Int J Biomater	10.1155/2021/7541555	2021	*
	In Vitro and In Vivo Evaluation of Silver Nanoparticles Phytosynthesized Using Raphanus sativus L. Waste Extracts.	Ungureanu C, Fierascu I, Fierascu RC, Costea T, Avramescu SM, Calinescu MF, Somoghi R, Pirvu C	Materials (Basel)	10.3390/ma14081845	2021	*
	Impact of Spreading Time to Recovery Rate in Suitability Test of Solid Agar Media.	Teramura H, Yasuda E, Naisei Y	Biocontrol Sci	10.4265/bio.26.43	2021	*
	Comparative Study of the Antimicrobial Activity of Selenium Nanoparticles With Different Surface Chemistry and Structure.	Filipovic N, Usjak D, Milenkovic MT, Zheng K, Liverani L, Boccaccini AR, Stevanovic MM	Front Bioeng Biotechnol	10.3389/fbioe.2020.624621	2021	*
	Evaluation of antibacterial activity of enterocin A-colicin E1 fusion peptide.	Fathizadeh H, Saffari M, Esmaeili D, Moniri R, Salimian M	Iran J Basic Med Sci	10.22038/ijbms.2020.47826.11004	2020	*
	Activity of Temporin A and Short Lipopeptides Combined with Gentamicin against Biofilm Formed by Staphylococcus aureus and Pseudomonas aeruginosa.	Paduszynska MA, Greber KE, Paduszynski W, Sawicki W, Kamysz W	Antibiotics (Basel)	10.3390/antibiotics9090566	2020	*
	The outlier Pseudomonas aeruginosa strain ATCC 9027 harbors a defective LasR quorum-sensing transcriptional regulator.	Garcia-Reyes S, Soto-Aceves MP, Cocotl-Yanez M, Gonzalez-Valdez A, Servin-Gonzalez L, Chavez GS	FEMS Microbiol Lett	10.1093/femsle/fnaa122	2020	*
	Survival strategy of Pseudomonas aeruginosa on the nanopillar topography of dragonfly (Pantala flavescens) wing.	Kamarajan BP, Muthusamy A	AMB Express	10.1186/s13568-020-01021-7	2020	*
	Prevention of Pseudomonas aeruginosa Biofilm Formation on Soft Contact Lenses by Allium sativum Fermented Extract (BGE) and Cannabinol Oil Extract (CBD).	Di Onofrio V, Gesuele R, Maione A, Liguori G, Liguori R, Guida M, Nigro R, Galdiero E	Antibiotics (Basel)	10.3390/antibiotics8040258	2019	*
	Influence of Short Cationic Lipopeptides with Fatty Acids of Different Chain Lengths on Bacterial Biofilms Formed on Polystyrene and Hydrogel Surfaces.	Paduszynska MA, Maciejewska M, Neubauer D, Golacki K, Szymukowicz M, Bauer M, Kamysz W	Pharmaceutics	10.3390/pharmaceutics11100506	2019	*
	Enhanced synergistic effects of xylitol and isothiazolones for inhibition of initial biofilm formation by Pseudomonas aeruginosa ATCC 9027 and Staphylococcus aureus ATCC 6538.	Zhou G, Peng H, Wang YS, Huang XM, Xie XB, Shi QS	J Oral Sci	10.2334/josnusd.18-0102	2019	*
	Antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus.	Saito H, Sakakibara Y, Sakata A, Kurashige R, Murakami D, Kageshima H, Saito A, Miyazaki Y	PLoS One	10.1371/journal.pone.0217504	2019	*
	Design, synthesis, and biological activity of novel ammonium salts containing sterically hindered phenolic fragment and phosphoryl group.	Starodubtseva RR, Gibadullina EM, Pazilova NB, Sapunova AS, Voloshina AD, Sudakov IA, Vyshtakalyuk AB, Pudovik MA, Burilov AR, Bukharov SV	Medchemcomm	10.1039/c8md00481a	2018	*
	Total Phenolic Content and Antioxidant and Antibacterial Activities of Pereskia bleo.	Johari MA, Khong HY	Adv Pharmacol Sci	10.1155/2019/7428593	2019	*
	Bioactive Glass Granules Inhibit Mature Bacterial Biofilms on the Surfaces of Cochlear Implants.	Hoing B, Kirchhoff L, Arnolds J, Hussain T, Buer J, Lang S, Arweiler-Harbeck D, Steinmann J	Otol Neurotol	10.1097/MAO.0000000000002021	2018	*
	Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.	Consoli GML, Granata G, Picciotto R, Blanco AR, Geraci C, Marino A, Nostro A	Medchemcomm	10.1039/c7md00527j	2017	*
	Macroalgae Extracts From Antarctica Have Antimicrobial and Anticancer Potential.	Martins RM, Nedel F, Guimaraes VBS, da Silva AF, Colepicolo P, de Pereira CMP, Lund RG	Front Microbiol	10.3389/fmicb.2018.00412	2018	*
	Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin.	Masadeh MM, Alzoubi KH, Al-Azzam SI, Al-Buhairan AM	Clin Pharmacol	10.2147/CPAA.S148448	2017	*
	Effect of low-concentration rhamnolipid biosurfactant on Pseudomonas aeruginosa transport in natural porous media.	Liu G, Zhong H, Jiang Y, Brusseau ML, Huang J, Shi L, Liu Z, Liu Y, Zeng G	Water Resour Res	10.1002/2016WR019832	2017	*
	Synergistic effect of Carum copticum and Mentha piperita essential oils with ciprofloxacin, vancomycin, and gentamicin on Gram-negative and Gram-positive bacteria.	Talei GR, Mohammadi M, Bahmani M, Kopaei MR	Int J Pharm Investig	10.4103/jphi.JPHI_12_17	2017	*
	Evolution of Aggregate Structure in Solutions of Anionic Monorhamnolipids: Experimental and Computational Results.	Eismin RJ, Munusamy E, Kegel LL, Hogan DE, Maier RM, Schwartz SD, Pemberton JE	Langmuir	10.1021/acs.langmuir.7b00078	2017	*
	Comparison of the compact dry TC method with the standard method ISO 21149:2006 for determining aerobic colony counts in cosmetic emulsion.	De Vaugelade S, Aime M, Farcette N, Maurel E, Lacour T, Thomas C, Bouchonnet S, Pirnay S	Int J Cosmet Sci	10.1111/ics.12343	2016	*
	Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents.	Masadeh MM, Alzoubi KH, Al-Azzam SI, Khabour OF, Al-Buhairan AM	Pathogens	10.3390/pathogens5010028	2016	*
	Antimicrobial activities of endophytic fungi of the Sri Lankan aquatic plant Nymphaea nouchali and chaetoglobosin A and C, produced by the endophytic fungus Chaetomium globosum.	Dissanayake RK, Ratnaweera PB, Williams DE, Wijayarathne CD, Wijesundera RLC, Andersen RJ, de Silva ED	Mycology	10.1080/21501203.2015.1136708	2016	*
	Corneal Biofilms: From Planktonic to Microcolony Formation in an Experimental Keratitis Infection with Pseudomonas Aeruginosa.	Saraswathi P, Beuerman RW	Ocul Surf	10.1016/j.jtos.2015.07.001	2015	*
	Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance.	Ayaz M, Subhan F, Ahmed J, Khan AU, Ullah F, Ullah I, Ali G, Syed NI, Hussain S	J Biol Res (Thessalon)	10.1186/s40709-015-0028-1	2015	*
	Bioluminescence-based measurement of viability of Pseudomonas aeruginosa ATCC 9027 harbouring plasmid-based lux genes under the control of constitutive promoters.	Shah N, Naseby DC	J Appl Microbiol	10.1111/jam.12635	2014	*
	Green synthesis of silver nanoparticles using Delphinium denudatum root extract exhibits antibacterial and mosquito larvicidal activities.	Suresh G, Gunasekar PH, Kokila D, Prabhu D, Dinesh D, Ravichandran N, Ramesh B, Koodalingam A, Vijaiyan Siva G	Spectrochim Acta A Mol Biomol Spectrosc	10.1016/j.saa.2014.02.030	2014	*
	[Structural components and peculiarities of Pseudomonas aeruginosa biofilm organization].	Balko OB, Avdieieva LV	Mikrobiol Z		2010	*
	Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus attachment patterns on glass surfaces with nanoscale roughness.	Mitik-Dineva N, Wang J, Truong VK, Stoddart P, Malherbe F, Crawford RJ, Ivanova EP	Curr Microbiol	10.1007/s00284-008-9320-8	2008	*
	Direct contact membrane method for evaluating preservative efficacy in solid cosmetics.	Tran AT, Hitchins AD, Collier SW	Int J Cosmet Sci	10.1111/j.1467-2494.1990.tb00533.x	1990	*
	Phytochemical Analysis and Antibacterial Activity of Achillea coarctata Poir. Essential Oils.	Stamenkovic JG, Petrovic GM, Dordevic AS	Chem Biodivers	10.1002/cbdv.202200578	2022	*
	Component Composition and Biological Activity of Various Extracts of Onosma gmelinii (Boraginaceae).	Shilov SV, Ustenova GO, Kiyekbayeva LN, Korotetskiy IS, Kudashkina NV, Zubenko NV, Parenova RA, Jumagaziyeva AB, Iskakbayeva ZA, Kenesheva ST	Int J Biomater	10.1155/2022/4427804	2022	*
	Defining Exposure Predictors of Meropenem That Are Associated with Improved Survival for Severe Bacterial Infection: A Preclinical PK/PD Study in Sepsis Rat Model.	Wang Y, Liu L, Wu Q, Yin Q, Xie F	Antibiotics (Basel)	10.3390/antibiotics11111660	2022	*
	A Multidisciplinary Approach in Examining the Susceptibility to Microbial Attack of Polyacrylic and Polyurethane Resins Used in Art Restoration.	Campana R, Sabatini L, Giorgi L, Pettinari G, Valentini L, Gobbi P	Int J Mol Sci	10.3390/ijms231911725	2022	*

References

#572	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 1128

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#20218

Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )

#41819 ; Curators of the CIP;
#47686 Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 22801

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#67770 Japan Collection of Microorganism (JCM) ; Curators of the JCM;

#68369

Automatically annotated from API 20NE .

#68382

Automatically annotated from API zym .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

#81969

Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.: StrainInfo: A central database for resolving microbial strain identifiers . ( DOI 10.60712/SI-ID3893.1 )

#116095 Collection of Institut Pasteur ; Curators of the CIP; CIP 82.118
* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Pseudomonas aeruginosa in external resources:
SILVA
BRENDA
PANGAEA
StrainInfo
GBIF

Pseudomonas aeruginosa ATCC 9027

Pseudomonas aeruginosa ATCC 9027

Change proposal

Change proposal